NMS · Analyst Forecast

Kestra Medical Technologies, Ltd. (KMTS) Analyst Forecast

$29.18 NMS: KMTS Market Cap $1.74B

Revenue and earnings estimates published by analysts covering Kestra Medical Technologies, Ltd. (KMTS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Kestra Medical Technologies, Ltd., analysts forecast revenue rising from $92.97T in 2026 to $411.70T in 2031; the average estimate for 2031 earnings per share is $0.00; 7 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

Measure	Value
Current priceWhat the share trades at now.	$29.18
Consensus targetThe average of the price targets analysts have published.	$31.50
Median targetThe middle target, less affected by a single outlier.	$31.00
Highest targetThe most optimistic published target.	$34.00
Lowest targetThe most pessimistic published target.	$30.00
Difference from priceHow far the consensus target sits from today’s price.	+8.0%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2026	$92.96T	$92.97T	$94.68T	5
2027	$140.69T	$140.88T	$140.94T	7
2028	$190.98T	$196.04T	$201.34T	7
2029	$250.99T	$259.73T	$268.10T	6
2030	$335.66T	$342.84T	$349.14T	5
2031	$403.08T	$411.70T	$419.27T	3

Earnings per share forecast

Year	Low	Average	High	Analysts
2026	$-2.37	$-2.34	$-2.30	5
2027	$-2.48	$-2.45	$-2.42	7
2028	$-2.29	$-2.05	$-1.92	7
2029	$-1.99	$-1.67	$-1.38	6
2030	$-1.14	$-1.11	$-1.08	5
2031	$0.00	$0.00	$0.00	3

Kestra Medical Technologies, Ltd. (KMTS) forecast — frequently asked questions

What is the analyst price target for Kestra Medical Technologies, Ltd.?

Analysts covering Kestra Medical Technologies, Ltd. (KMTS) have a consensus price target of $31.50, 8.0% above the current price of $29.18. Published targets range from $30.00 to $34.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Kestra Medical Technologies, Ltd.'s earnings?

The average analyst estimate for Kestra Medical Technologies, Ltd. (KMTS) earnings per share in 2031 is 0.00, with individual estimates between 0.00 and 0.00.

How much revenue is Kestra Medical Technologies, Ltd. expected to make?

Analysts forecast Kestra Medical Technologies, Ltd. (KMTS) revenue of $411.70T in 2031, based on 3 published estimates.

How many analysts cover KMTS?

7 analysts contribute estimates for Kestra Medical Technologies, Ltd. (KMTS). Thin coverage makes an average less reliable.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.